SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001102624-16-003375
Filing Date
2016-09-14
Accepted
2016-09-14 08:05:33
Documents
3
Period of Report
2016-09-14

Document Format Files

Seq Description Document Type Size
1 ACASTI PHARMA INC. 6-K acasti6k.htm 6-K 17088
2 EXHIBIT 99.1 exh99_1.htm EX-99.1 15308
3 image0.jpg GRAPHIC 105229
  Complete submission text file 0001102624-16-003375.txt   178388
Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3
Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 161884200
SIC: 2834 Pharmaceutical Preparations